Morgan Stanley Reiterates Overweight on Mindray

Morgan Stanley reiterated its Overweight rating on Mindray MR. On Wednesday, MR closed the day at $21.36.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: ReiterationAnalyst RatingsHealth CareHealth Care EquipmentMorgan Stanley
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!